Entamoeba histolytica IgG ELISA
- Regulatory Status
- EU: CE
- Kit size
- 12 x 8
- Method
- ELISA
- Incubation time
- 1 x 1h, 1 x 30min, 1 x 15min
- Standard range
- cut-off index
- Specimen / Volumes
- 10 µL serum
- Substrate / isotope
- TMB 450 nm
Entamoeba histolytica is an anaerobe parasite forming cysts which have four small nuclei and measure 10-15 μm in diameter. The cysts are sturdy and resist adverse environmental conditions. After ingestion by a susceptible host (invertebrates and vertebrates including humans), its wall is disrupted by the formation of a small opening through which an amoeba emerges. The amoeba divides serially through three cycles giving rise to eight uninucleate trophozoites from one cyst which are motile and measure 20-30 μm in diameter. Some of the trophozoites then invade the tissues of the large intestine and may erode them so extensively that they gain entrance into the bloodstream. Thus, amoebae can reach all parts of the body. Infection with Entamoeba histolytica has worldwide distribution. It is the causative agent of amoebiasis and amoebic dysentery and inhabits the lumen and mucosa of the large intestine, predominantly the transverse colon and cecum. Extra intestinal amoebiasis can afflict any organ or tissue. The majority of infected individuals are free of symptoms; this high incidence of asymptomatic carriers complicates matters. Those who are symptomatic experience a wide range of manifestations. Members of all age groups and both sexes are infected. The risk of infection increases with inadequate sanitary conditions. An increased prevalence of amoebiasis is found among people, who have an increased risk of exposure in the agricultural occupations and in male homosexuals. Infection may be identified by
For concrete data please consult the Instruction for Use in the download box on the top right side.
Our comprehensive immunoassay portfolio includes a number of specialty diagnostic immunoassays for endocrinology, immunology and autoimmunity, as well as for diagnosis of multiple infectious diseases. We are pioneers and market leaders in saliva diagnostics, with over 40 years of experience supplying a broad portfolio of luminescence- and ELISA-based tests, including our highly acclaimed HMGB1 and MuSK-Ab ELISAs.
And as experts in laboratory automation, we can support our customers with the protocols for open ELISA platforms, such as the Freedom EVOlyzer or Thunderbolt®.
All products are only available for sale to laboratory professionals and may not be available in all countries. Availability and regulatory status may vary across regions depending on local country-specific registration. Please always read and follow the instructions for use.
All of our assays have been designed and manufactured to meet the highest global regulatory requirements and quality standards. Tecan is certified under ISO 9001:2015, ISO 13485:2016 and is audited by a notified body according to Medical Device Single Audit Program (MDSAP).

As part of the Tecan Group, we have a leading market position in diagnostics and research, with over 40 years of experience in the development, manufacture and supply of enzyme-, radiolabel- and luminescence-based immunoassays.
Our range of high-quality immunoassays is supported by a diverse portfolio of automated solutions, making us the perfect partner for you and your customers.
At Tecan, we are driven to improve people’s lives and health.